InvestorPlace
Cingulate (NASDAQ:CING) stock is soaring over 160% in early trading and trending on many financial news websites. The rally was sparked by the company’s announcement that the Nasdaq exchange would postpone delisting its shares for several weeks. Cingulate has developed a potential treatment for attention deficit hyperactivity disorder (ADHD). Last month, CING reported that Nasdaq had decided to delist its shares. This came after its stockholders’ equity had dropped below the minimum level requir
